GlaxoSmithKline and Amicus Therapeutics commence second phase III study of Amigal™ for Fabry disease
12 September 2011 | By GSK
The first patient has commenced dosing in a Phase III global registration study...
List view / Grid view
News
Analyses find type 2 diabetes patients treated with BYDUREON™ experienced reduction in cardiovascular risk factors
12 September 2011 | By Eli Lilly and Company
Results presented at EASD 2011...
Lyxumia® (lixisenatide) one-step regimen as effective as two-step regimen in improving glycemic control in type 2 diabetes
12 September 2011 | By Sanofi
New phase III data from GetGoal-F1 study...
IDBS Celebrates Queen’s Award for International Trade
IDBS, a global provider of innovative data management, analytics and modeling solutions, was awarded the Queen's Award for Enterprise in the International Trade category on Tuesday September 6.
B&W Tek announces enhanced high resolution Raman spectrometer
9 September 2011 | By B&W Tek, Inc.
B&W Tek, Inc., has recently enhanced the industry leading i-Raman® high resolution TE cooled Raman spectrometer...
Lapatinib clinical trial update
9 September 2011 | By GSK
A planned interim review of early data from ALTTO a Phase III, four arm study of adjuvant lapatinib (Tykerb/Tyverb®), trastuzumab, has resulted in a change to the ongoing study...
Abbott initiates international ABSORB BTK clinical trial for treatment of below-the-knee critical limb ischemia
8 September 2011 | By Abbott
Abbott announced the initiation of ABSORB BTK...
PerkinElmer to acquire Caliper Life Sciences for approximately $600 million
8 September 2011 | By PerkinElmer
PerkinElmer, Inc. has signed a definitive agreement to acquire Caliper Life Sciences, Inc...
Bristol-Myers Squibb completes acquisition of Amira Pharmaceuticals
8 September 2011 | By Bristol-Myers Squibb Company
Bristol-Myers Squibb Company has completed its previously announced acquisition of privately held Amira Pharmaceuticals, Inc...
Roche named Dow Jones Sustainability Index leader in healthcare for third consecutive year
8 September 2011 | By Roche
Roche recognized as the most sustainable healthcare company globally in the DJSI...
Novartis receives EU approval for Votubia®
8 September 2011 | By Novartis
The European Commission has approved Votubia® (everolimus) tablets* for the treatment of patients aged 3 years and older...
Jens Eckstein named President of SR One
7 September 2011 | By GSK
Jens Eckstein has been named President of SR One, GSK’s independent healthcare venture organisation, effective 1 October...
Boehringer Ingelheim wins Frost & Sullivan Award
7 September 2011 | By Boehringer Ingelheim
Boehringer Ingelheim wins the '2011 European Bio Pharmaceutical Contract Manufacturing Competitive Strategy Leadership Award'...
Biogen Idec fully acquires Biogen Dompé joint ventures
6 September 2011 | By Biogen Idec
Biogen Idec will acquire 100% of Dompé shares in its joint ventures in both Italy and Switzerland...
Bayer confident in results of ROCKET AF study
6 September 2011 | By Bayer
Study to be reviewed by the FDA Cardiovascular and Renal Drugs Advisory Committee...
